Perera, Y.; Melão, A.; Ramón, A.C.; Vázquez, D.; Ribeiro, D.; Perea, S.E.; Barata, J.T.
Clinical-Grade Peptide-Based Inhibition of CK2 Blocks Viability and Proliferation of T-ALL Cells and Counteracts IL-7 Stimulation and Stromal Support. Cancers 2020, 12, 1377.
https://doi.org/10.3390/cancers12061377
AMA Style
Perera Y, Melão A, Ramón AC, Vázquez D, Ribeiro D, Perea SE, Barata JT.
Clinical-Grade Peptide-Based Inhibition of CK2 Blocks Viability and Proliferation of T-ALL Cells and Counteracts IL-7 Stimulation and Stromal Support. Cancers. 2020; 12(6):1377.
https://doi.org/10.3390/cancers12061377
Chicago/Turabian Style
Perera, Yasser, Alice Melão, Ailyn C. Ramón, Dania Vázquez, Daniel Ribeiro, Silvio E. Perea, and João T. Barata.
2020. "Clinical-Grade Peptide-Based Inhibition of CK2 Blocks Viability and Proliferation of T-ALL Cells and Counteracts IL-7 Stimulation and Stromal Support" Cancers 12, no. 6: 1377.
https://doi.org/10.3390/cancers12061377
APA Style
Perera, Y., Melão, A., Ramón, A. C., Vázquez, D., Ribeiro, D., Perea, S. E., & Barata, J. T.
(2020). Clinical-Grade Peptide-Based Inhibition of CK2 Blocks Viability and Proliferation of T-ALL Cells and Counteracts IL-7 Stimulation and Stromal Support. Cancers, 12(6), 1377.
https://doi.org/10.3390/cancers12061377